• English
    • Persian
  • English 
    • English
    • Persian
  • Login
View Item 
  •   KR-TBZMED Home
  • TBZMED Published Academics Works
  • Published Articles
  • View Item
  •   KR-TBZMED Home
  • TBZMED Published Academics Works
  • Published Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Effects of Vitex agnus and Flaxseed on cyclic mastalgia: A randomized controlled trial

Thumbnail
Date
2016
Author
Mirghafourvand, M
Mohammad-Alizadeh-Charandabi, S
Ahmadpour, P
Javadzadeh, Y
Metadata
Show full item record
Abstract
Objectives: Evidence on the effect of Vitex agnus and Flaxseed on cyclical mastalgia is not enough. This study aimed to assess the efficacy of V. agnus and Flaxseed on cyclical mastalgia. Design and setting: This randomized controlled trial was conducted on 159 women referred to health centers of Tabriz, Iran. Subjects were allocated into three groups (n= 53 per group) using block randomization. Interventions and Main outcome measures: Group I received 25 g daily Flaxseed powder and placebo of V. agnus; group II received daily 3.2-4.8 mg V. agnus tablet and placebo of Flaxseed and control group received both placebo. Nominal day breast pain was applied at baseline, first, and second month after the intervention. Data was analyzed using general linear model. Results: There was no statistical significant difference between the three groups in terms of socio-demographic characteristics and baseline values. The breast pain improved significantly in both intervention groups during the first and second month after intervention. Mean NDBP score was significantly lower than that in the control group at the first month after the intervention in the Flaxseed [adjusted mean difference: 3.1 (95% CI: 4.2 to 2.0)] and V. agnus groups [-3.3 (-4.3 to 2.2)] and the second month after the intervention in Flaxseed [-7.0 (-8.1 to 5.9)] and V. agnus groups [-6.4 (-7.5 to 5.3)]. Conclusion: Flaxseed and V. agnus are effective in short-term period in decreasing cyclical mastalgia. However, further studies are needed to examine the long-term effectiveness and sustainability of the effects after stopping the treatment in order to decide whether these alternative treatments are suitable to treat mastalgia or not. (C) 2015 Elsevier Ltd. All rights reserved.
URI
http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47189
Collections
  • Published Articles

Knowledge repository of Tabriz University of Medical Sciences using DSpace software copyright © 2018  HTMLMAP
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

All of KR-TBZMEDCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Knowledge repository of Tabriz University of Medical Sciences using DSpace software copyright © 2018  HTMLMAP
Contact Us | Send Feedback
Theme by 
Atmire NV